In many studies conducted up to present, it has been shown that p53 mutation was more frequent in lung, esophagus, stomach, bone, bladder, ovarian, and brain (except glioma) cancers as well as lymphoma and leukemia (8). This evidence concerns the gene TP53 and cancer.